Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii

被引:5
|
作者
Slarve, Matthew [1 ]
Reyna, Zeferino [1 ]
Burk, Elizabeth [1 ]
Ruiz-Delgado, Juan [1 ]
Li, Rachel [1 ]
Yan, Jun [1 ]
Luna, Brian [1 ]
Spellberg, Brad [2 ]
机构
[1] Keck Sch Med USC, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA
[2] Angeles Cty USC LACUSC Med Ctr, Los Angeles, CA USA
关键词
Acinetobacter baumannii; K antigen; monoclonal antibody; O antigen; antibiotic resistance; carbohydrates; therapeutic;
D O I
10.1128/aac.00086-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Acinetobacter baumannii is an extremely drug-resistant pathogen necessitating the development of new therapies. We seek to generate a cocktail of monoclonal antibodies (MAbs) that can target the full diversity of A. baumannii isolates. We have newly identified the antibody MAb5. Here, we demonstrate that MAb5 has broad binding against U.S. (n = 300) and international (n = 250) isolates (72.24% and 28.76%, respectively), likely targets O-antigen capsular carbohydrates, and exhibits protective efficacy in vivo. Acinetobacter baumannii is an extremely drug-resistant pathogen necessitating the development of new therapies. We seek to generate a cocktail of monoclonal antibodies (MAbs) that can target the full diversity of A. baumannii isolates.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Monoclonal antibodies against the iron regulated outer membrane proteins of Acinetobacter baumannii are bactericidal
    Goel V.K.
    Kapil A.
    BMC Microbiology, 1 (1) : 1 - 8
  • [32] Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus
    Wei, Ziping
    Feng, Jinhua
    Lin, Hung-Yu
    Mullapudi, Sombabu
    Bishop, Eric
    Tous, Guillermo I.
    Casas-Finet, Jose
    Hakki, Fadi
    Strouse, Robert
    Schenerman, Mark A.
    ANALYTICAL CHEMISTRY, 2007, 79 (07) : 2797 - 2805
  • [33] In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model
    Abuhussain, Safa S. Almarzoky
    Avery, Lindsay M.
    Abdelraouf, Kamilia
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (01)
  • [34] Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
    Wen, Kun
    Cai, Jian-Piao
    Fan, Xiaodi
    Zhang, Xiaojuan
    Luo, Cuiting
    Tang, Kai-Ming
    Shuai, Huiping
    Chen, Lin-Lei
    Zhang, Ricky Ruiqi
    Situ, Jianwen
    Tsoi, Hoi-Wah
    Wang, Kun
    Chan, Jasper Fuk-Woo
    Yuan, Shuofeng
    Yuen, Kwok-Yung
    Zhou, Hongwei
    To, Kelvin Kai-Wang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [35] Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice
    Guo San Jun
    Ren Shan
    Xie Yong En
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2018, 31 (02) : 155 - 158
  • [36] A Short Peptide of Autotransporter Ata Is a Promising Protective Antigen for Vaccination Against Acinetobacter baumannii
    Sun, Peng
    Li, Xin
    Pan, Chao
    Liu, Zhicheng
    Wu, Jun
    Wang, Hengliang
    Zhu, Li
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice
    GUO San Jun
    REN Shan
    XIE Yong En
    Biomedical and Environmental Sciences, 2018, 31 (02) : 155 - 158
  • [38] A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections
    Xiong, Yan Q.
    Estelles, Angeles
    Li, L.
    Abdelhady, Ni
    Gonzales, R.
    Bayer, Arnold S.
    Tenorio, Edgar
    Leighton, Anton
    Ryser, Stefan
    Kauvar, Lawrence M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (10)
  • [39] Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii
    Defraine, Valerie
    Schuermans, Joris
    Grymonprez, Barbara
    Govers, Sander K.
    Aertsen, Abram
    Fauvart, Maarten
    Michiels, Jan
    Lavigne, Rob
    Briers, Yves
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (06) : 3480 - 3488
  • [40] Osmotic Compounds Enhance Antibiotic Efficacy against Acinetobacter baumannii Biofilm Communities
    Falghoush, Azeza
    Beyenal, Haluk
    Besser, Thomas E.
    Omsland, Anders
    Call, Douglas R.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2017, 83 (19)